[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@RNAiAnalyst](/creator/twitter/RNAiAnalyst) "$PRME $EDIT $SANA.3 #CRISPR names up XXX% on strong volume + in short order none of them have raised"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942683220497346864) 2025-07-08 20:32:27 UTC 19.5K followers, 11.8K engagements "@deusexdividend X years $VERV was about to start p2 in 2025. Phase 3s should then start in 2027. So likely X 1/2 years if safety deemed approriate for ASCVD population. $LLY"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944862132668895631) 2025-07-14 20:50:40 UTC 19.5K followers, XXX engagements "$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942960763590599039) 2025-07-09 14:55:19 UTC 19.5K followers, 3621 engagements "@Sanctuary_Bio Thanks for that I owe you. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945580253021147214) 2025-07-16 20:24:14 UTC 19.5K followers, 1104 engagements "$PRME has become a cult stock because the potential is limitless and they are far ahead of the prime editing game including IP"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942258102406873480) 2025-07-07 16:23:11 UTC 19.4K followers, 17K engagements "Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942337968103940439) 2025-07-07 21:40:33 UTC 19.5K followers, 6307 engagements "Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945593959566188597) 2025-07-16 21:18:42 UTC 19.5K followers, 9785 engagements "$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945590783299457446) 2025-07-16 21:06:04 UTC 19.5K followers, 17.5K engagements "$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944679151429910692) 2025-07-14 08:43:34 UTC 19.5K followers, 5039 engagements "@GeneInvesting 'good day for gene therapy'.seriously $SRPT just dropped their gene therapy pipeline except for X LGMD type cause of PRV. :)"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945845469285880050) 2025-07-17 13:58:06 UTC 19.5K followers, XXX engagements "Hormone Replacement Therapy.one of @drmakaryFDA's favorite health interventions. Any playable stocks in that regard"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944867556470481038) 2025-07-14 21:12:14 UTC 19.5K followers, 5053 engagements "I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945911746549498014) 2025-07-17 18:21:28 UTC 19.5K followers, 1661 engagements "$ARWR bought some after-hours for giggles. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945579848560218124) 2025-07-16 20:22:37 UTC 19.5K followers, 2919 engagements "$apge priced for perfection or near that with $2.8B market cap on eve of critical atopic derm read-out. Science risk seems low but then again why are they first in category Also pin action on $nktr of interest"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942104658488565894) 2025-07-07 06:13:27 UTC 19.5K followers, 4978 engagements "I never considered $MREO because I didn't like their AATD program but $470M market cap and $60M in cash.what am I missing $RARE"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943049441805766901) 2025-07-09 20:47:41 UTC 19.5K followers, 5875 engagements "$apge: ' we are accelerating development plan by running another higher dose trial'. Mmh yep 'accelerating' by taking another year before arriving at p3 dose"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942195426494435471) 2025-07-07 12:14:08 UTC 19.5K followers, 4217 engagements "$srpt been traveling but aren't they due to report limb girdle data Too busy with salvaging Elevidys and keeping company liquid"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1940722085208486363) 2025-07-03 10:39:36 UTC 19.5K followers, 3484 engagements "@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942179396934062296) 2025-07-07 11:10:26 UTC 19.4K followers, XXX engagements "HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944706566860439969) 2025-07-14 10:32:31 UTC 19.5K followers, 8700 engagements "$SRPT does restructuring largely take bankruptcy risk off table.assuming no more Elevidys safety surprises + exon skippers staying on market"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945749107621961976) 2025-07-17 07:35:12 UTC 19.5K followers, 2228 engagements "I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942338563875770722) 2025-07-07 21:42:55 UTC 19.5K followers, 2413 engagements "$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943607302998597953) 2025-07-11 09:44:26 UTC 19.5K followers, 6334 engagements "A XX minute heads-up. Sounds serious. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945576893601706426) 2025-07-16 20:10:53 UTC 19.5K followers, 4614 engagements "#biotech Would keep some powder dry. It's obvious that Trump admin wants to let this escalate on August X (=Liberation Day 2) but it will be TACO again a few days thereafter. TACO was essential foe my XXX% gain in X months"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944306796174217466) 2025-07-13 08:03:58 UTC 19.4K followers, 4010 engagements "$KALV oral on-demand pill for HAE approved by FDA $APGE anti-IL13 p2 hits in atopic dermatitis $JSPR CS Urticaria drug efficacious but manufacturing issues Quite the morning in the #dermatology space"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942209228522856750) 2025-07-07 13:08:59 UTC 19.5K followers, 5632 engagements "$srpt been out all day but -X% suggests it's kneejerk to $capr CRL and #FDA not believing in medicines for DMD"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943728660491460659) 2025-07-11 17:46:40 UTC 19.5K followers, 4079 engagements "Get ready for some volatility as Trump gets ready to fire #Fed chair Powell. Ultimately would be very positive for #biotech. Could be a great buying op"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945512936191021521) 2025-07-16 15:56:44 UTC 19.5K followers, 2073 engagements "On the X hand #FDA said it wants to promote #wearables enabling people access to their health info👏. On the other hand it is now threatening to take action against a blood pressure wearable maker for not having it licensed as a medical device. wtf"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945747758729642252) 2025-07-17 07:29:50 UTC 19.5K followers, 1775 engagements "@GeneInvesting especially the impressive subQ data for CNS. platform. $srpt $arwr"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945809743668252910) 2025-07-17 11:36:08 UTC 19.5K followers, XXX engagements "$APGE clearly efficacious though pbo response on high end. On safety XX% non-infective #conjunctivitis taking median of XX days to resolve. I'll trade that in for an ISR any day -- $NKTR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942175248159219733) 2025-07-07 10:53:57 UTC 19.5K followers, 16.7K engagements "$KALV 50k on-demand treatments per year.pill option should grow usage say 60k EKTERLY stands out: oral rapid response clean safety -- only insurance will limit market share XX% market share-- $600M rev MC: $760M well financed Expect solid profits in '26 PT: $25"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942627017259635175) 2025-07-08 16:49:07 UTC 19.5K followers, 2432 engagements "Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942914682471194785) 2025-07-09 11:52:12 UTC 19.5K followers, 2901 engagements "$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1934948230745202794) 2025-06-17 12:16:22 UTC 19.5K followers, 2916 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RNAiAnalyst
"$PRME $EDIT $SANA.3 #CRISPR names up XXX% on strong volume + in short order none of them have raised" @RNAiAnalyst on X 2025-07-08 20:32:27 UTC 19.5K followers, 11.8K engagements
"@deusexdividend X years $VERV was about to start p2 in 2025. Phase 3s should then start in 2027. So likely X 1/2 years if safety deemed approriate for ASCVD population. $LLY" @RNAiAnalyst on X 2025-07-14 20:50:40 UTC 19.5K followers, XXX engagements
"$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X" @RNAiAnalyst on X 2025-07-09 14:55:19 UTC 19.5K followers, 3621 engagements
"@Sanctuary_Bio Thanks for that I owe you. $SRPT" @RNAiAnalyst on X 2025-07-16 20:24:14 UTC 19.5K followers, 1104 engagements
"$PRME has become a cult stock because the potential is limitless and they are far ahead of the prime editing game including IP" @RNAiAnalyst on X 2025-07-07 16:23:11 UTC 19.4K followers, 17K engagements
"Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent" @RNAiAnalyst on X 2025-07-07 21:40:33 UTC 19.5K followers, 6307 engagements
"Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR" @RNAiAnalyst on X 2025-07-16 21:18:42 UTC 19.5K followers, 9785 engagements
"$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY" @RNAiAnalyst on X 2025-07-16 21:06:04 UTC 19.5K followers, 17.5K engagements
"$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO" @RNAiAnalyst on X 2025-07-14 08:43:34 UTC 19.5K followers, 5039 engagements
"@GeneInvesting 'good day for gene therapy'.seriously $SRPT just dropped their gene therapy pipeline except for X LGMD type cause of PRV. :)" @RNAiAnalyst on X 2025-07-17 13:58:06 UTC 19.5K followers, XXX engagements
"Hormone Replacement Therapy.one of @drmakaryFDA's favorite health interventions. Any playable stocks in that regard" @RNAiAnalyst on X 2025-07-14 21:12:14 UTC 19.5K followers, 5053 engagements
"I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)" @RNAiAnalyst on X 2025-07-17 18:21:28 UTC 19.5K followers, 1661 engagements
"$ARWR bought some after-hours for giggles. $SRPT" @RNAiAnalyst on X 2025-07-16 20:22:37 UTC 19.5K followers, 2919 engagements
"$apge priced for perfection or near that with $2.8B market cap on eve of critical atopic derm read-out. Science risk seems low but then again why are they first in category Also pin action on $nktr of interest" @RNAiAnalyst on X 2025-07-07 06:13:27 UTC 19.5K followers, 4978 engagements
"I never considered $MREO because I didn't like their AATD program but $470M market cap and $60M in cash.what am I missing $RARE" @RNAiAnalyst on X 2025-07-09 20:47:41 UTC 19.5K followers, 5875 engagements
"$apge: ' we are accelerating development plan by running another higher dose trial'. Mmh yep 'accelerating' by taking another year before arriving at p3 dose" @RNAiAnalyst on X 2025-07-07 12:14:08 UTC 19.5K followers, 4217 engagements
"$srpt been traveling but aren't they due to report limb girdle data Too busy with salvaging Elevidys and keeping company liquid" @RNAiAnalyst on X 2025-07-03 10:39:36 UTC 19.5K followers, 3484 engagements
"@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR" @RNAiAnalyst on X 2025-07-07 11:10:26 UTC 19.4K followers, XXX engagements
"HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN" @RNAiAnalyst on X 2025-07-14 10:32:31 UTC 19.5K followers, 8700 engagements
"$SRPT does restructuring largely take bankruptcy risk off table.assuming no more Elevidys safety surprises + exon skippers staying on market" @RNAiAnalyst on X 2025-07-17 07:35:12 UTC 19.5K followers, 2228 engagements
"I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA" @RNAiAnalyst on X 2025-07-07 21:42:55 UTC 19.5K followers, 2413 engagements
"$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa" @RNAiAnalyst on X 2025-07-11 09:44:26 UTC 19.5K followers, 6334 engagements
"A XX minute heads-up. Sounds serious. $SRPT" @RNAiAnalyst on X 2025-07-16 20:10:53 UTC 19.5K followers, 4614 engagements
"#biotech Would keep some powder dry. It's obvious that Trump admin wants to let this escalate on August X (=Liberation Day 2) but it will be TACO again a few days thereafter. TACO was essential foe my XXX% gain in X months" @RNAiAnalyst on X 2025-07-13 08:03:58 UTC 19.4K followers, 4010 engagements
"$KALV oral on-demand pill for HAE approved by FDA $APGE anti-IL13 p2 hits in atopic dermatitis $JSPR CS Urticaria drug efficacious but manufacturing issues Quite the morning in the #dermatology space" @RNAiAnalyst on X 2025-07-07 13:08:59 UTC 19.5K followers, 5632 engagements
"$srpt been out all day but -X% suggests it's kneejerk to $capr CRL and #FDA not believing in medicines for DMD" @RNAiAnalyst on X 2025-07-11 17:46:40 UTC 19.5K followers, 4079 engagements
"Get ready for some volatility as Trump gets ready to fire #Fed chair Powell. Ultimately would be very positive for #biotech. Could be a great buying op" @RNAiAnalyst on X 2025-07-16 15:56:44 UTC 19.5K followers, 2073 engagements
"On the X hand #FDA said it wants to promote #wearables enabling people access to their health info👏. On the other hand it is now threatening to take action against a blood pressure wearable maker for not having it licensed as a medical device. wtf" @RNAiAnalyst on X 2025-07-17 07:29:50 UTC 19.5K followers, 1775 engagements
"@GeneInvesting especially the impressive subQ data for CNS. platform. $srpt $arwr" @RNAiAnalyst on X 2025-07-17 11:36:08 UTC 19.5K followers, XXX engagements
"$APGE clearly efficacious though pbo response on high end. On safety XX% non-infective #conjunctivitis taking median of XX days to resolve. I'll trade that in for an ISR any day -- $NKTR" @RNAiAnalyst on X 2025-07-07 10:53:57 UTC 19.5K followers, 16.7K engagements
"$KALV 50k on-demand treatments per year.pill option should grow usage say 60k EKTERLY stands out: oral rapid response clean safety -- only insurance will limit market share XX% market share-- $600M rev MC: $760M well financed Expect solid profits in '26 PT: $25" @RNAiAnalyst on X 2025-07-08 16:49:07 UTC 19.5K followers, 2432 engagements
"Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB" @RNAiAnalyst on X 2025-07-09 11:52:12 UTC 19.5K followers, 2901 engagements
"$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA" @RNAiAnalyst on X 2025-06-17 12:16:22 UTC 19.5K followers, 2916 engagements
/creator/twitter::409194010/posts